Dr. Ashwani Dhar is a physician-entrepreneur and healthcare technology executive based in the San Francisco Bay Area, California. He serves as CEO & Chairman of ThinkRoman Ventures, CEO of Kairos R&D Solutions, and is the founder of TRPharma.
A former Chief Medical Information Officer at Cerner/Oracle Health, Dr. Dhar has spent much of his career bridging medicine and technology. His work spans clinical care, healthcare research, digital health, artificial intelligence, and software development — with a focus on turning real-world healthcare challenges into practical, scalable solutions.
He works at the intersection of clinical medicine, research, and technology — bringing together the perspective of a physician, entrepreneur, and product builder.
01 · On camera
InterviewGenomics Gupshup · MapmyGenome
Watch on YouTube
HealthThinkRoman TV
Watch on YouTube
BusinessKarnataka Current News
Watch on YouTube
TV InterviewMysuru News 21
Watch on YouTube02 · In his own words
03 · Ventures
Three companies, one thesis. Each lives on its own — follow the link to go deeper.
CEO · Founder
A specialized clinical research organization (CRO) — AI-enabled trials, patient recruitment, real-world evidence, and the Kairodox document platform.
Full profileFounder
A doctor-led pharmaceutical division. WHO-GMP formulations — KashMOX 625, One87 Plus, KashCAL PLUS — priced for the people who take them.
Full profileCEO & Chairman
The health-tech venture studio behind it all — 20+ products across care, clinical data, and access, the umbrella for Kairos and TrPharma.
Full profile04 · On the move
From @ash.dharWhy we build — a leader's note on ThinkRoman's mission
From @ash.dharBridging clinical care and technology at ThinkRoman
From @ash.dharVenture building in health-tech — the ThinkRoman way
Speaking engagementSpeaking on healthcare innovation
InterviewAn interview on the work behind ThinkRoman05 · Writing
Notes from a physician-builder in the middle of an AI and healthcare moment.
Read on Medium AI & Health TechHuman weakness in conversational AI — and what anchoring bias in medicine reveals about how large language models handle context.
Read on Medium HealthcareFour years after the $28 billion acquisition, the numbers are in — and they tell a story every tech company eyeing healthcare should read.
Read on Medium HealthcareThe symptoms overlap more than you think — and guessing wrong delays getting better.
Read on Medium06 · Contact
Sponsors, sites, clinicians, and builders — if it touches clinical research, health data, or getting medicine to more people, I'd like to hear about it.